The N‐terminal dipeptide Tyr‐d‐Ala of a p‐selective agonist, dermorphin tetrapeptide (DT, H‐Tyr‐d‐Ala‐Phe‐Gly‐NH2) and δ‐selective agonist deltorphin C (DEL‐C, H‐Tyr‐d‐Ala‐Phe‐Asp‐Val‐Val‐Gly‐NH2) was changed into an aminodiacyl moiety. The relevant synthetic step is a nucleophilic substitution of bromine from a chiral 2‐bromopropanamide by the amino group of tyrosine, with overall retention of configuration. The resulting pseudo tetra‐ and heptapeptides I‐VI were characterized for μ and δ‐opioid receptor binding properties using [3H]DAGO and [3H]DPDPE, respectively, and in a bioassay using guinea pig ileum (GPI) and mouse vas deferens (MVD). As a result of chemical alteration of N‐terminal dipeptide moiety, all synthesized analogs showed considerable reduction in opioid receptor affinity compared to μ and δ‐prototypes (500‐fold on the μ‐site, analog I, and 125‐fold on the δ‐site, analog IV). Interestingly, analogs I and IV showed moderate antagonist activity, respectively, on GPI and ...

Single Diastereomeric Desaminotyrosylalanyl Tetra- and Heptapeptides with Opioid Antagonistic Activity

SALVADORI, Severo;MARCHETTI, Paolo;
1995

Abstract

The N‐terminal dipeptide Tyr‐d‐Ala of a p‐selective agonist, dermorphin tetrapeptide (DT, H‐Tyr‐d‐Ala‐Phe‐Gly‐NH2) and δ‐selective agonist deltorphin C (DEL‐C, H‐Tyr‐d‐Ala‐Phe‐Asp‐Val‐Val‐Gly‐NH2) was changed into an aminodiacyl moiety. The relevant synthetic step is a nucleophilic substitution of bromine from a chiral 2‐bromopropanamide by the amino group of tyrosine, with overall retention of configuration. The resulting pseudo tetra‐ and heptapeptides I‐VI were characterized for μ and δ‐opioid receptor binding properties using [3H]DAGO and [3H]DPDPE, respectively, and in a bioassay using guinea pig ileum (GPI) and mouse vas deferens (MVD). As a result of chemical alteration of N‐terminal dipeptide moiety, all synthesized analogs showed considerable reduction in opioid receptor affinity compared to μ and δ‐prototypes (500‐fold on the μ‐site, analog I, and 125‐fold on the δ‐site, analog IV). Interestingly, analogs I and IV showed moderate antagonist activity, respectively, on GPI and ...
1995
G., Balboni; Salvadori, Severo; F., D'Angeli; Marchetti, Paolo; L. H., Lazarus; S. D., Bryant; C., Bianchi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/533828
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact